These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 2483436

  • 1. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F.
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

  • 8. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
    Alicandri C, Fariello R, Boni E, Zaninelli A, Muiesan G.
    J Cardiovasc Pharmacol; 1989 Dec; 14 Suppl 8():S77-82. PubMed ID: 2483444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multicenter study on the clinical efficacy of chronic ibopamine administration.
    Dei Cas L, Barilli AC, Metra M, Fracalossi C, Lomanto B, Santambrogio S, Pinca L, Longhini C, Cavicchi E, Maggi GC.
    Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [Abstract] [Full Text] [Related]

  • 14. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA, Nara AR, Pospisil RA, Stoddard GJ, Schleman M.
    Pharmacotherapy; 1993 Jan; 13(3):218-23. PubMed ID: 8100627
    [Abstract] [Full Text] [Related]

  • 15. [Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
    Morimoto Y, Kasai A, Nagano K, Umino M, Kakuta Y, Iwata J, Hamada M, Konishi T, Nakano T.
    Kokyu To Junkan; 1989 Jul; 37(7):773-8. PubMed ID: 2799097
    [Abstract] [Full Text] [Related]

  • 16. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH.
    J Cardiovasc Pharmacol; 1989 Jul; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP, Lodola E.
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [Abstract] [Full Text] [Related]

  • 18. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S, Terrachini V, Canale C, Bruzzone F, Licciardello L, Marchetti GV.
    J Cardiovasc Pharmacol; 1989 Aug; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Ferrari V, Sher D, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.